BioSpace News Archive

Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), and KYE Pharmaceuticals Inc. (“KYE”), today announced receipt of a favorable decision from the Federal Court of Canada (“Court”) setting aside for the second time the decision of Canada’s national healthcare regulatory agency, Health Canada, to approve Ruzurgi® (amifampridine) for Lambert-Eaton Myasthenic Syndrome (“LEMS”) patients.

Amyris, Inc. today announced that it has closed the acquisition of the assets of MenoLabs, LLC.

Dermavant Sciences today announced that new data from the Phase 3 PSOARING 3 long-term extension study of tapinar cream.

Shineco, Inc. announced that on March 4, 2022, the Company has signed a strategic cooperation framework agreement on Shineco’s Weifang Life Science Industrial Park Project with the Development Service Center of Weifang Binhai Science and Technology Innovation Park in Shandong Province to build one of China’s first city-level tumor classification diagnosis and treatment centers and an online telemedicine service platform, which would constitute Shineco’s tumor diagnosis and treatment platform.

The global health coach market size is projected to hit around USD 25.95 billion by 2030 from valued at USD 14.48 billion in 2021, registered growth at a CAGR of 6.7% from 2022 to 2030.

The global precision medicine market size is predicted to hit around US$ 140.69 billion by 2028 from valued at US$ 66.1 billion in 2021, growing at a CAGR of 11.5% over the forecast period 2021 to 2030.

According to Precedence Research, the global surgical equipment market size was valued at USD$ 9.3 billion in 2021 and is predicted to be worth around US$ 15.08 billion by 2028.